Search

everythinglearnresearchcommunity

for

Search:↓

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Clinicians should consider individual factors and communicate risks and benefits when prescribing ritlecitinib for adolescent alopecia areata.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Ritlecitinib works well and is safe for treating alopecia areata.

Retinoids are effective for various skin conditions and hair loss but have serious side effects, so low doses are recommended.

Tofacitinib, a hair regrowth treatment, may worsen acne.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Both treatments improved alopecia areata, but methotrexate caused more skin darkening, while triamcinolone caused skin lightening and thinning.

Isotretinoin can cause hair loss, and reducing the dose or using supplements like vitamin D and iron may help.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Upadacitinib is effective and safe for treating severe Alopecia Areata in adolescents.

Tofacitinib treatment for hair loss may worsen acne.

Isotretinoin was not effective in treating facial lichen planopilaris.

Transepidermal drug delivery effectively treated areata alopecia with minimal side effects.

Isotretinoin treatment increases p53 levels in the skin, which may explain its effectiveness against acne.

Isotretinoin treatment increases p53 levels in the skin, which may explain its effectiveness against acne.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Oral isotretinoin temporarily improved skin symptoms in a child with IFAP syndrome.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

Acitretin effectively prevented skin cancer in a patient with late-onset Rothmund-Thomson syndrome.

The new synthetic retinoid RO 13-6298 effectively treated severe psoriasis at low doses with manageable side effects.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Combining isotretinoin and dapsone effectively treated a challenging scalp condition.